EC Healthcare

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG3037S1021
HKD
0.56
-0.02 (-3.45%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Mar'18
Mar'17
Net Sales
3,875.38
2,919.50
2,080.40
1,948.50
1,852.45
1,307.64
964.93
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
3,875.38
2,919.50
2,080.40
1,948.50
1,852.45
1,307.64
964.93
Raw Material Cost
3,200.71
2,166.45
1,560.94
1,298.57
942.70
783.61
603.82
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
1,289.82
906.22
734.16
672.15
550.12
341.28
277.87
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
71.67
52.81
26.42
18.06
2.74
43.23
29.72
Selling and Distribution Expenses
548.66
422.00
332.56
310.70
477.16
189.72
112.07
Other Expenses
-136.15
-95.90
-76.06
-69.02
-55.29
-38.45
-30.76
Total Expenditure (Excl Depreciation)
3,749.37
2,588.45
1,893.50
1,609.27
1,419.86
973.33
715.89
Operating Profit (PBDIT) excl Other Income
126
331.1
186.9
339.20000000000005
432.59999999999997
334.3
249
Other Income
42.30
31.97
28.96
23.61
31.93
27.78
4.17
Operating Profit (PBDIT)
755.04
795.39
525.73
612.25
526.27
399.72
292.36
Interest
71.67
52.81
26.42
18.06
2.74
43.23
29.72
Exceptional Items
27.23
11.87
71.47
12.00
-15.07
11.29
11.15
Gross Profit (PBDT)
674.67
753.05
519.47
649.93
909.75
524.02
361.11
Depreciation
586.74
432.37
309.86
245.78
61.75
37.62
29.17
Profit Before Tax
123.86
322.08
260.91
360.40
446.71
330.15
244.61
Tax
29.16
50.91
40.30
50.25
65.58
52.02
41.11
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
69.65
197.50
192.86
286.58
361.11
279.22
200.70
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
69.65
197.50
192.86
286.58
361.11
279.22
200.70
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
37.37
73.00
32.73
23.70
23.40
-1.09
2.79
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
107.03
270.50
225.59
310.27
384.50
278.14
203.50
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
1,854.48
1,881.25
1,268.75
1,002.73
1,042.00
820.85
778.46
Earnings per share (EPS)
0.06
0.17
0.19
0.29
0.37
0.28
0.21
Diluted Earnings per share
0.06
0.17
0.19
0.29
0.37
0.28
0.21
Operating Profit Margin (Excl OI)
3.25%
11.34%
8.98%
17.6%
23.35%
25.57%
26.84%
Gross Profit Margin
18.34%
25.84%
27.44%
31.11%
27.45%
28.13%
28.37%
PAT Margin
1.8%
6.76%
9.27%
14.71%
19.49%
21.35%
20.8%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2023 is 32.74% vs 40.33% in Mar 2022

stock-summary

Consolidate Net Profit

YoY Growth in year ended Mar 2023 is -60.44% vs 19.90% in Mar 2022

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2023 is -6.64% vs 53.66% in Mar 2022

stock-summary

Interest

YoY Growth in year ended Mar 2023 is 35.80% vs 100.00% in Mar 2022

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2023 has fallen from Mar 2022

Compare Annual Results Of EC Healthcare With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(HKD)
Change(%)
Net Sales
3,875.38
385.86
3,489.52
904.35%
Other Operating Income
0.00
0.00
0.00
Total Operating income
3,875.38
385.86
3,489.52
904.35%
Raw Material Cost
3,200.71
146.51
3,054.20
2,084.64%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
1,289.82
199.65
1,090.17
546.04%
Power Cost
0
0
0.00
Manufacturing Expenses
71.67
0.30
71.37
23,790.00%
Selling and Distribution Expenses
548.66
177.37
371.29
209.33%
Other Expenses
-136.15
-15.59
-120.56
-773.32%
Total Expenditure (Excl Depreciation)
3,749.37
367.91
3,381.46
919.10%
Operating Profit (PBDIT) excl Other Income
126.01
17.95
108.06
602.01%
Other Income
42.30
22.97
19.33
84.15%
Operating Profit (PBDIT)
755.04
54.50
700.54
1,285.39%
Interest
71.67
0.30
71.37
23,790.00%
Exceptional Items
27.23
21.83
5.40
24.74%
Gross Profit (PBDT)
674.67
239.35
435.32
181.88%
Depreciation
586.74
9.23
577.51
6,256.88%
Profit Before Tax
123.86
66.80
57.06
85.42%
Tax
29.16
5.98
23.18
387.63%
Provisions and contingencies
0.00
0
0.00
Profit After Tax
69.65
60.82
8.83
14.52%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
69.65
60.82
8.83
14.52%
Share in Profit of Associates
0.00
0
0.00
Minority Interest
37.37
0.00
37.37
Other related items
0.00
0.00
0.00
Consolidated Net Profit
107.03
60.82
46.21
75.98%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
1,854.48
1,233.54
620.94
50.34%
Earnings per share (EPS)
0.06
0.09
-0.03
-33.33%
Diluted Earnings per share
0.06
0.09
-0.03
-33.33%
Operating Profit Margin (Excl OI)
3.25%
5.78%
0.00
-2.53%
Gross Profit Margin
18.34%
19.70%
0.00
-1.36%
PAT Margin
1.80%
15.76%
0.00
-13.96%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 387.54 Million
in Mar 2023

Figures in Million
stock-summary

YoY Growth in year ended Mar 2023 is 32.74% vs 40.33% in Mar 2022

Annual - Consolidate Net Profit
Consolidate Net Profit 10.70 Million
in Mar 2023

Figures in Million
stock-summary

YoY Growth in year ended Mar 2023 is -60.44% vs 19.90% in Mar 2022

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 71.27 Million
in Mar 2023

Figures in Million
stock-summary

YoY Growth in year ended Mar 2023 is -6.64% vs 53.66% in Mar 2022

Annual - Interest
Interest 7.17 Million
in Mar 2023

Figures in Million
stock-summary

YoY Growth in year ended Mar 2023 is 35.80% vs 100.00% in Mar 2022

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 3.25%
in Mar 2023

Figures in %
stock-summary

YoY Growth in year ended Mar 2023 has fallen from Mar 2022